HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation.

Abstract
Gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid (Gd-EOB-DTPA) is a hepatocyte-specific MRI contrast agent. Because the hepatic uptake of Gd-EOB-DTPA depends on the integrity of the hepatocyte mass, this uptake can be quantified to assess liver function. We report the relationship between the extent of Gd-EOB-DTPA uptake and the degree of liver fibrosis. T1-weighted volume-interpolated breath-hold examination (VIBE) sequences with fat suppression were acquired before and 20 minutes after contrast injection. Strong correlations of the uptake characteristics of Gd-EOB-DTPA with the relative enhancement (RE) of the liver parenchyma and the grade of fibrosis/cirrhosis, classified using the Ishak scoring system, were observed. The subdivisions between the grades of liver fibrosis based on RE were highly significant for all combinations, and a ROC revealed sensitivities ≥82% and specificities ≥87% for all combinations. MR imaging is a satisfactorily sensitive method for the assessment of liver fibrosis/cirrhosis.
AuthorsNiklas Verloh, Kirsten Utpatel, Michael Haimerl, Florian Zeman, Claudia Fellner, Stefan Fichtner-Feigl, Andreas Teufel, Christian Stroszczynski, Matthias Evert, Philipp Wiggermann
JournalScientific reports (Sci Rep) Vol. 5 Pg. 15408 (Oct 19 2015) ISSN: 2045-2322 [Electronic] England
PMID26478097 (Publication Type: Journal Article)
Chemical References
  • Contrast Media
  • gadolinium ethoxybenzyl DTPA
  • Gadolinium DTPA
Topics
  • Adult
  • Aged
  • Biopsy
  • Contrast Media
  • Female
  • Gadolinium DTPA
  • Humans
  • Image Enhancement
  • Image Processing, Computer-Assisted
  • Liver Cirrhosis (diagnosis, pathology, surgery)
  • Magnetic Resonance Imaging (methods, standards)
  • Male
  • Middle Aged
  • ROC Curve
  • Risk Factors
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: